Diseases /
Malignant Ovarian Endometrioid Tumor
Back to Diseases List
Associated Genetic Biomarkers
Overview
NCI Definition: An invasive malignant neoplasm that arises from the ovary characterized by the presence of malignant, endometrial-type cells. It includes endometrioid adenocarcinoma and carcinosarcoma. [1]
Malignant ovarian endometrioid tumors most frequently harbor alterations in TP53, PIK3CA, KRAS, PTEN, and ARID1A [2].
TP53 Mutation, TP53 c.217-c.1178 Missense, TP53 Missense, PIK3CA Mutation, and PTEN Mutation are the most common alterations in malignant ovarian endometrioid tumor [2].
Clinical Trials
Significant Genes in Malignant Ovarian Endometrioid Tumor
Disease Details
References
1. National Cancer Institute. NCI Thesaurus Version 18.11d. https://ncit.nci.nih.gov/ncitbrowser/ [2018-08-28]. [2018-09-21].
2. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 8. This dataset does not represent the totality of the genetic landscape; see paper for more information.
3. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.